Correction: Albumin nano-encapsulation of piceatannol enhances its anticancer potential in colon cancer via down regulation of nuclear p65 and hif-1ff (cancers 2020, 12, 113)

Alaa A.A. Aljabali, Hamid A. Bakshi, Faruck L. Hakkim, Yusuf A. Haggag, Khalid M. Al-Batanyeh, Mazhar S. Al Zoubi, Bahaa Al-Trad, Mohamed M. Nasef, Saurabh Satija, Meenu Mehta, Kavita Pabreja, Vijay Mishra, Mohammed Khan, Salem Abobaker, Ibrahim M. Azzouz, Harish Dureja, Ritesh M. Pabari, Ashref Ali K. Dardouri, Prashant Kesharwani, Gaurav GuptaShakti Dhar Shukla, Parteek Prasher, Nitin B. Charbe, Poonam Negi, Deepak N. Kapoor, Dinesh Kumar Chellappan, Mateus Webba Da Silva, Paul Thompson, Kamal Dua, Paul McCarron, Murtaza M. Tambuwala

Research output: Contribution to journalComment/debatepeer-review

3 Scopus citations

Abstract

The authors wish to make the following corrections to this paper [1]: in Figure 2A,C on page 12, some panels appear to show overlapping areas; all images have been now corrected and the different treatment conditions shows the corresponding representative image.

Original languageEnglish (US)
Article number3587
Pages (from-to)1-4
Number of pages4
JournalCancers
Volume12
Issue number12
DOIs
StatePublished - Dec 2020
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020, MDPI AG. All rights reserved.

Fingerprint

Dive into the research topics of 'Correction: Albumin nano-encapsulation of piceatannol enhances its anticancer potential in colon cancer via down regulation of nuclear p65 and hif-1ff (cancers 2020, 12, 113)'. Together they form a unique fingerprint.

Cite this